Rajmohan M, Rao Umadevi Krishnamohan, Joshua Elizabeth, Rajasekaran Saraswathy Thillai, Kannan Ranganathan
Department of Oral and Maxillofacial Pathology, K.S.R Institute of Dental Science and Research, Tiruchengode, India.
J Oral Maxillofac Pathol. 2012 Sep;16(3):325-9. doi: 10.4103/0973-029X.102476.
Carcinoma in an early stage of development is hard to detect clinically because the lesion may not be palpable and color of the lesional tissue is not necessarily different from the color of the surrounding mucosa. In order to improve the efficacy of the diagnosis, techniques are being developed to complement clinical examination and to facilitate the identification of initial carcinomas.
To find out the efficacy of chemiluminescent illumination (ViziLite™) for the diagnosis in precancer and cancer patients and compare this result to toluidine blue staining and oral exfoliative cytology.
This study was done in 3 groups. Each group consists of 10 cases. Group I consists of normal appearing mucosa. Group II and III consist of clinically diagnosed pre-cancer and clinically suggestive of cancer respectively. Chemiluminescent illumination, toluidine blue supravital staining, oral exfoliative cytology and biopsy were performed in all cases.
SPSS version 10.05 was used to calculate positive and negative predictive values.
In Group I, all 10 patients showed negative result to ViziLite™. 8 patients showed positivity and 2 patients showed negativity to ViziLite™ test in Group II. 9 patients were positive and one patient was negative for ViziLite™.
Chemiluminescent illumination test was sensitive for precancerous and cancerous lesions, which presented as keratotic lesions and red-white lesions. It showed negative result to erosive lesions. Toluidine blue staining test was reliable in precancerous and cancerous lesions, which present as erosive and red-white lesions. It showed negative result to keratotic lesions. Oral exfoliative cytology has diagnostic value in cancer patients than in precancer patients. These Results indicate that chemiluminescent illumination test is relatively reliable and accurate than toluidine blue staining test and useful chair side diagnostic test.
处于早期发展阶段的癌在临床上很难检测到,因为病变可能无法触及,且病变组织的颜色不一定与周围黏膜的颜色不同。为了提高诊断效果,正在开发一些技术来辅助临床检查并便于识别早期癌。
了解化学发光照明(ViziLite™)对癌前病变和癌症患者诊断的有效性,并将此结果与甲苯胺蓝染色和口腔脱落细胞学检查结果进行比较。
本研究分为3组。每组10例。第一组为外观正常的黏膜。第二组和第三组分别为临床诊断的癌前病变和临床疑似癌症。对所有病例均进行化学发光照明、甲苯胺蓝活体染色、口腔脱落细胞学检查和活检。
使用SPSS 10.05版软件计算阳性和阴性预测值。
在第一组中,所有10例患者的ViziLite™检测结果均为阴性。在第二组中,8例患者的ViziLite™检测呈阳性,2例呈阴性。在第三组中,9例患者的ViziLite™检测呈阳性,1例呈阴性。
化学发光照明检测对表现为角化性病变和红白相间病变的癌前病变和癌性病变敏感,对糜烂性病变检测结果为阴性。甲苯胺蓝染色检测对表现为糜烂性和红白相间病变的癌前病变和癌性病变可靠,对角化性病变检测结果为阴性。口腔脱落细胞学检查对癌症患者的诊断价值高于癌前病变患者。这些结果表明,化学发光照明检测比甲苯胺蓝染色检测相对可靠和准确,是一种有用的椅旁诊断检测方法。